Nventa Biopharmaceuticals Corporation - Comparative Business Analysis Snapshot

Business Description
Nventa Biopharmaceuticals Corporation. The Group's principal activity is to discover, develop and commercialize innovative stress protein-based immunotherapeutics, also known as therapeutic vaccines, which are used for the treatment of infectious diseases and cancers. The Group uses a specific and unique class of proteins, called stress proteins, to regulate immune responses for therapeutic applications. The Group has market for its products in the United States, Canada and other Countries.

Competitor Analysis
This analysis compares Nventa Biopharmaceuticals Corporation with three other companies in closely related industry sectors.

The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports